HESA Committee Report
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
In accordance with its Order of Reference of Wednesday, May 29, 2024, your committee has considered Bill C-368, An Act to amend the Food and Drugs Act (natural health products), and agreed on Thursday, November 28, 2024, to report it with the following amendments: Clause 1 That Bill C-368, in Clause 1, be amended by replacing lines 7 to 11 on page 1 with the following: “therapeutic product means (a) a drug or device; (b) any combination of drugs and devices; or (c) a natural health product, within the meaning of the Natural Health Products Regulations, that contains nicotine, or its salts, and is used in nicotine replacement therapy; (produit thérapeutique)” New Clause 1.1 That Bill C-368 be amended by adding after line 11 on page 1 the following new clause: “1.1 The Act is amended by adding the following after section 2.2: 2.21 Despite the definition therapeutic product in section 2, sections 21.3 to 21.303 and the regulations made under paragraphs 30(1.2)(f.01) and (f.02) apply to a natural health product within the meaning of the Natural Health Products Regulations.” New Clause 3.1 That Bill C-368 be amended by adding after line 13 on page 1 the following new clause: “3.1 Subsection 30(1.2) of the Act is amended by adding the following after paragraph (f): (f.01) respecting the recall of natural health products within the meaning of the Natural Health Products Regulations; (f.02) prescribing penalties for the contravention of subsection 21.3(3) in respect of a natural health product within the meaning of the Natural Health Products Regulations or of the regulations made under paragraph (f.01);” |
Your committee has ordered a reprint of Bill C-368, as amended, as a working copy for the use of the House of Commons at the report stage. |
A copy of the relevant Minutes of Proceedings (Meetings Nos. 132, 135, 136, 138 to 140 and 142) is tabled. |